Fate Therapeutics, Inc. (FATE)
NASDAQ·Healthcare·Biotechnology
$2.37
+1.94%
Mkt Cap $280.91M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (21 analysts)
$4.00
Range $4.00 – $4.00
Implied Upside
+69.1%
Consensus $4.00 vs current $2.37
NASDAQ·Healthcare·Biotechnology
$2.37
+1.94%
Mkt Cap $280.91M
Buy
2
Hold
0
Sell
0
Price Target (21 analysts)
$4.00
Range $4.00 – $4.00
+69.1%
Consensus $4.00 vs current $2.37